Skip to main content
Erschienen in: Journal of Cancer Education 2/2019

15.11.2017

Skin Cancer Awareness and Sun Protection Behavior Before and Following Treatment Among Skin Cancer-Treated Patients

verfasst von: Robabeh Abedini, Maryam Nasimi, Pedram Nourmohammad Pour, Ifa Etesami, Safa Al-Asiri, Hamid Reza Tohidinik

Erschienen in: Journal of Cancer Education | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

There is little known about illness perception in patients with skin tumors. We conducted this study to investigate Iranian patients’ understanding of skin tumors, and to evaluate their sun-protective behavior changes after treatment of skin cancer. Patients with a skin biopsy of basal cell carcinoma were asked to complete questionnaires. A total of 110 patients were enrolled in the study. Patients were mostly referred to our tumor clinic from rural areas. At the skin cancer perception investigation, 63% of patients did not consider their disease as a long-lasting situation. Besides, 45.4% of patients consider their illness as a serious condition which significantly affecting their lives. Our patients had a strong belief in treatment control (81%) and 81% of them also described worries about their skin cancer. The leading causes of skin cancer as assumed by patients were: history of skin cancer (37.4%), poor medical care in the past (36.4%), extreme sun exposure (31.5%), and lack of sun protection (27.5%). In regard to sun-protective behavior after treatment of skin cancer, 55.4% of patients showed no changes or even negative change in their sun-protective behavior, But 44.5% of the patients changed their sun-protective behavior in a positive way which was statically significant (P ≤ 0.001). Our study demonstrates how our patients with skin cancer perceive their disease and we need to educate our patients, considering diseases’ aspects, causes and symptoms. This is of great value as dermatologists should be aware of patients’ perceptions of their disease in order to improve patients’ knowledge through educating more about different aspects of disease.
Literatur
2.
Zurück zum Zitat El Ghissassi F, Baan R, Straif K, Grosse Y, Secretan B, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, WHO International Agency for Research on Cancer Monograph Working Group (2009) A review of human carcinogens—part D: radiation. Lancet Oncol 10(8):751–752. https://doi.org/10.1016/S1470-2045(09)70213-X CrossRef El Ghissassi F, Baan R, Straif K, Grosse Y, Secretan B, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, WHO International Agency for Research on Cancer Monograph Working Group (2009) A review of human carcinogens—part D: radiation. Lancet Oncol 10(8):751–752. https://​doi.​org/​10.​1016/​S1470-2045(09)70213-X CrossRef
5.
Zurück zum Zitat de Vries E, Arnold M, Altsitsiadis E, Trakatelli M, Hinrichs B, Stockfleth E, Coebergh J, on behalf of the EPIDERM Group (2012) Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010–2050. Br J Dermatol 167(Suppl 2):53–62. https://doi.org/10.1111/j.1365-2133.2012.11087.x CrossRefPubMed de Vries E, Arnold M, Altsitsiadis E, Trakatelli M, Hinrichs B, Stockfleth E, Coebergh J, on behalf of the EPIDERM Group (2012) Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010–2050. Br J Dermatol 167(Suppl 2):53–62. https://​doi.​org/​10.​1111/​j.​1365-2133.​2012.​11087.​x CrossRefPubMed
8.
Zurück zum Zitat Sattler U, Thellier S, Sibaud V, Taïeb C, Mery S, Paul C, Meyer N (2014) Factors associated with sun protection compliance: results from a nationwide cross-sectional evaluation of 2215 patients from a dermatological consultation. Br J Dermatol 170(6):1327–1335. https://doi.org/10.1111/bjd.12966 CrossRefPubMed Sattler U, Thellier S, Sibaud V, Taïeb C, Mery S, Paul C, Meyer N (2014) Factors associated with sun protection compliance: results from a nationwide cross-sectional evaluation of 2215 patients from a dermatological consultation. Br J Dermatol 170(6):1327–1335. https://​doi.​org/​10.​1111/​bjd.​12966 CrossRefPubMed
10.
Zurück zum Zitat Leventhal H, Nerenz DR, Steele DS (1984) Illness representations and coping with health threats. In: Baum A, Singer JE (eds) Handbook of psychology and health. Erlbaum, New York, pp 221–252 Leventhal H, Nerenz DR, Steele DS (1984) Illness representations and coping with health threats. In: Baum A, Singer JE (eds) Handbook of psychology and health. Erlbaum, New York, pp 221–252
11.
Zurück zum Zitat Leventhal HBY, Brownlee S, Diefenbach M et al (1997) Illness representations: theoretical foundations. In: Petrie KJ, Weinman J (eds) Perceptions of health and illness: current research and applications. Harwood Academic Publishers, Amsterdam, pp 19–45 Leventhal HBY, Brownlee S, Diefenbach M et al (1997) Illness representations: theoretical foundations. In: Petrie KJ, Weinman J (eds) Perceptions of health and illness: current research and applications. Harwood Academic Publishers, Amsterdam, pp 19–45
Metadaten
Titel
Skin Cancer Awareness and Sun Protection Behavior Before and Following Treatment Among Skin Cancer-Treated Patients
verfasst von
Robabeh Abedini
Maryam Nasimi
Pedram Nourmohammad Pour
Ifa Etesami
Safa Al-Asiri
Hamid Reza Tohidinik
Publikationsdatum
15.11.2017
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 2/2019
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-017-1299-z

Weitere Artikel der Ausgabe 2/2019

Journal of Cancer Education 2/2019 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.